All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010

Journal of Infection and Public Health

Volumn 7, Issue 2, 2014, Pages 133-144

  Schmid, D ^a   Kuo, H W ^a   Simons, E ^a   Kanitz, E E ^a   Wenisch, J ^b   Allerberger, F ^a   Wenisch, C ^b  

^a AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Age; All cause death; Clostridium difficile infection; Diarrhea; Underlying disease

Indexed keywords

ADENOVIRUS; AEROMONAS; AGED; ARTICLE; AUSTRIA; CAMPYLOBACTER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; FEMALE; HUMAN; INFECTIOUS DIARRHEA; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; ROTAVIRUS; SALMONELLA; SHIGELLA; YERSINIA;

AGE; ALL-CAUSE DEATH; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; UNDERLYING DISEASE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRIA; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; DIARRHEA; FEMALE; HUMANS; MALE; MIDDLE AGED; NOROVIRUS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84896076876     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2013.07.010     Document Type: Article

References (31)

1. Hall A.J., Curns A.T., McDonald L.C., Parashar U.D., Lopman B.A. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012, 55:216-223.
2. Moudgal V., Sobel J.D. Clostridium difficile colitis: a review. Hosp Pract (Minneap) 2012, 40:139-148.
3. Mitchell B.G., Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrob Resist Infect Control 2012, 1:20. 10.1186/2047-2994-1-20.
4. Huttunen R., Aittoniemi J. Risk factors for mortality in patients with Clostridium difficile infection. Clin Infect Dis 2012, 54:1214.
5. Kotila S.M., Virolainen A., Snellman M., Ibrahem S., Jalava J., Lyytikäinen O. Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008. Clin Microbiol Infect 2011, 17:888-893.
6. McGowan A.P., Lalayiannis L.C., Sarma J.B., Marshall B., Martin K.E., Welfare M.R. Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008. J Hosp Infect 2011, 77:11-15.
7. Wilson V., Cheek L., Satta G., Walker-Bone K., Cubbon M., Citron D., et al. Predictors of death after Clotridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010, 50:77-81.
8. Scallan E., Hoekstra R.M., Angulo F.J., Tauxe R.V., Widdowson M.A., Roy S.L., et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
9. Bauer M.P., Kuijper E.J., van Dissel J.T. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
10. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
11. Anon Standardization and quality assurance in clinical microbiology 2001, [in German], [accessed 24.01.13]. http://www.lkh-leoben.at/cms/dokumente/10002410_2148978/5ea41f2a/RL_Mikrobiologie_V01.pdf.
12. Oh D.Y., Gaedicke G., Schreier E. Viral agents of acute gastroenteritis in German children: prevalence and molecular diversity. J Med Virol 2003, 71:82-93.
13. Jansen A., Stark K., Kunkel J., Schreier E., Ignatius R., Liesenfeld O., et al. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis 2008, 8:143.
14. Lucado J., Gould C., Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009 2012, HCUP Statistical Brief #124. US Department of Health and Human Services, Agency for Health Care Policy and Research, Rockville, MD.
15. Abdel Samie A., Traub M., Bachmann K., Kopischke K., Theilmann L. Risk factors for recurrence of Clostridium difficile-associated diarrhea. Hepatogastroenterology 2012, 60:126.
16. Kelly C.P. Can we identify patients at high risk of recurrent Clostridium difficile infection. Clin Microbiol Infect 2012, 18(S6):21-27.
17. Vasallo F.J., Martín-Rabadán P., Alcalá L., García-Lechuz J.M., Rodríguez-Créixems M., Bouza E. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis 1998, 26:535-536.
18. Tang B.S., Chan J.F., Chen M., Tsang O.T., Mok M.Y., Lai R.W. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol 2010, 17:1132-1138.
19. Delaloye J., Merlani G., Petignat C., Wenger A., Zaman K., Monnerat C., et al. Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization. Eur J Clin Microbiol Infect Dis 2004, 23:751-758.
20. Zahar J.R., Schwebel C., Adrie C., Garrouste-Orgeas M., Français A., Vesin A., et al. Outcome of ICU patients with Clostridium difficile infection. Crit Care 2012, 16:R215.
21. Morrison R.H., Hall N.S., Said M., Rice T., Groff H., Brodine S.K., et al. Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 2011, 53:1173-1178.
22. Sailhamer E.A., Carson K., Chang Y., Zacharias N., Spaniolas K., Tabbara M., et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 2009, 144:433-440.
23. Wiegand P.N., Nathwani D., Wilcox M.H., Stephens J., Shelbaya A., Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 2012, 81:1-14.
24. Bauer M.P., Notermans D.W., van Benthem B.H., Brazier J.S., Wilcox M.H., Rupnik M., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377(9759):63-73.
25. Dubberke E.R., Butler A.M., Reske K.A., Agniel D., Olsen M.A., D'Angelo G., et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008, 14:1031-1038.
26. Dudukgian H., Sie E., Gonzalez-Ruiz C., Etzioni D.A., Kaiser A.M. C. difficile colitis-predictors of fatal outcome. J Gastrointest Surg 2010, 14:315-322.
27. Wenisch J.M., Schmid D., Tucek G., Kuo H.W., Allerberger F., Michl V., et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection 2012, 40:479-484.
28. Hensgens M.P., Goorhuis A., Dekkers O.M., van Benthem B.H., Kuijper E.J. All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis 2013, 56(8):1108-1116.
29. Bloomfield M.G., Sherwin J.C., Gkrania-Klotsas E. Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect 2012, 82:1-12.
30. Balmer O., Tanner M. Prevalence and implications of multiple-strain infections. Lancet Infect Dis 2011, 11:868-878.
31. Hota S.S., Achonu C., Crowcroft N.S., Harvey B.J., Lauwers A., Gardam M.A. Determining mortality rates attributable to Clostridium difficile. Infection Emerg Infect Dis 2012, 18(2):305-307.